MetDrugs meeting: at the frontier between coordination chemistry and nanotechnology
- News 12 December 2017 2042 hits
Anna Roig, researcher at the Nanoparticles and Nanocomposites (NN) group, participated on November 30 at the MetDrugs meeting, this time focused on nanostructures and metal-drugs complexes for biomedical applications. Anna's talk was entitled “Iron oxide nanoparticles come in all flavours”. The scientific meeting was organized by the MetDrugs network and ICN2.
The MetDrugs meeting took place at the Seminar Hall of the Catalan Institute of Nanoscience and Nanotechnology (ICN2), and counted with a group of experts in the design and development of new nanostructures and coordination complexes for biomedicla applications from various research centers and universities: Universidad Complutense de Madrid (UCM), Institut Lavoisier de Versailles, Universidad de Murcia, Universidad Autónoma de Madrid (UAM), Instituto de Ciencia de Materiales de Aragón (ICMA), Institut de Recerca de la Vall d’Hebrón (VHIR), Universitat Autònoma de Barcelona (UAB), Institut de Ciència de Materials de Barcelona (ICMAB-CSIC) and Institut Català de Nanociència i Nanotecnologia (ICN2)
The MetDrugs network is composed of 10 Spanish research groups of various expertise in chemistry, nanotechnology and biology, and is representing 12 different Spanish universities and institutions. The principal aim of the networks is to develop potential drugs and diagnostic tools based on efficient metal-based systems. The main goal of MetDrugs is to share knowledge and competencies to develop innovative strategies, and applied them through cooperative projects.
The scientific committee of this event was formed by Dr. Fernando Novio / Dr. Daniel Ruiz-Molina (ICN2), and Dr. Mercé Capdevila / Dr. Oscar Palacios (UAB).
Related Topics: Meetings Participation